Abby Statler (@StatlerA16) header
Abby Statler (@StatlerA16) profile picture

Abby Statler

@StatlerA16
Joined December 2015
  • Tweets168
  • Following151
  • Followers114
26Media
Photo by Abby Statler (@StatlerA16)Photo by Abby Statler (@StatlerA16)Photo by Abby Statler (@StatlerA16)Photo by Abby Statler (@StatlerA16)Photo by Abby Statler (@StatlerA16)Photo by Abby Statler (@StatlerA16)Photo by Abby Statler (@StatlerA16)Photo by Abby Statler (@StatlerA16)Photo by Abby Statler (@StatlerA16)Photo by Abby Statler (@StatlerA16)
Winston was so excited to meet @MikkaelSekeres - he fist pumped 👊🏻 for the first time 😀 ! After all that practicing for #ASH19, I’m pretty confident Winston’s first words will be hematologic malignancy 😂 – at Shaker Heights, OH
Mikkael A. Sekeres MD, MS (@MikkaelSekeres) profile pictureMikkael A. Sekeres MD, MS
@MikkaelSekeres25 Feb 2020
After giving two talks and one poster at #ASH19 while 8 months pregnant, @StatlerA16 lets me hold another of her flawless presentations!!! What a beautiful boy! 🤗🤗🤗
Image from Mikkael A. Sekeres MD, MS (@MikkaelSekeres)
1
28
Such important work! – at Shaker Heights, OH
Laura C. Michaelis (@lauracmichaelis) profile pictureLaura C. Michaelis@lauracmichaelis12 Dec 2019
With Enough Patient Support, Cancer Care Disparities Vanish medpagetoday.com/meetingcove…

With Enough Patient Support, Cancer Care Disparities Vanish

Treatment access, outcomes similar at safety-net center that goes above and beyond

medpagetoday.com
2
Go @MeganKruseMD 👏 – at Cleveland, OH
This Post is from an account that no longer exists. Learn more
4
Covers of all >60 issues @ASHClinicalNews that @MikkaelSekeres has edited - >2200 different articles he’s had to review to ensure subject-verb agreement and that “data” are plural, delete meaningless stuff like “at this point in time”, and change “utilize” to “use” @Jenifer_one_N
Image from David Steensma, MD (@DavidSteensma)
2
11
2
59
Allison Winter, MD, discusses a collaborative effort focused on the relapse of patients with follicular lymphoma: #ASH19

#ASH19

1
7
1
16
Dr. Advani elucidates the prognostic impact of MRD and the outcomes relevant to novel therapies in ALL - excellent educational session 🤓#ASH19 @CleClinicMD #CleClincCancer
Image from Abby Statler (@StatlerA16)
1
4
.@BldCancerDoc provides tips for utilizing social media to share information and engage with others at #ASH19:
17
1
37
Thrilled that work presented at #ASH19 related to SES #disparities in peds #leukemia is receiving media attention. I’m hopeful that w/ increased awareness we can accelerate progress toward a deeper mechanistic understanding & #healthequity. @UCSFChildrens healio.com/news/online/%7Bb7… – at Florida, USA
This Post is from an account that no longer exists. Learn more
4
11
Abby Statler retweeted
The ASCO Post (@ASCOPost) profile picture
The ASCO Post@ASCOPost9 Dec 2019
Mikkael A. Sekeres, MD, on Newly Diagnosed Hematologic Malignancies: Early Trial Findings on Glasdegib Plus Azacitidine ascopost.com/videos/2019-ash… #hematology #ASH19 #leusm @MikkaelSekeres @CleClinicMD
Image from The ASCO Post (@ASCOPost)
6
6
Calm, cool, collected, and convincing! Great presentation of Pacritinib trial results from @AaronGerds!
Image from Mikkael A. Sekeres MD, MS (@MikkaelSekeres)
1
3
1
35
200mg BID may be the optimal dose of Pacritinib for patients with MF, @AaronGerds giving another fantastic presentation at #ASH2019! – at Florida, USA
Image from Abby Statler (@StatlerA16)
4
Looks like @MukherzSudipto is having a blast here presenting his work 🤗 - enjoying the complete Orlando experience! – at Florida, USA
This Post is from an account that no longer exists. Learn more
1
4
Replying to @MukherzSudipto
@MukherzSudipto doing fabulous job discussing risk factors and outcome in @ASH_hematology Guidelines for Older Adults with AML at #ASH19!
Image from Mikkael A. Sekeres MD, MS (@MikkaelSekeres)
3
9
In any haiku Myelodysplastic Syndromes Fits on just one line #ASHaiku #ASH19
Aaron Gerds MD, MS (@AaronGerds) profile pictureAaron Gerds MD, MS@AaronGerds8 Dec 2019
Let’s get the #ASHaiku train rolling! 🚆Call out to: @doctorpemm @szusmani @lauracmichaelis @hamiltkyb @SurbhiSidanaMD @BldCancerDoc @mpndoc @MikkaelSekeres @jmikhaelmd #ASH19
1
2
29
When you feel like you have balcony seats for a play at the theater but it’s @MikkaelSekeres presenting on glasdegib + azacitidine in AML and MDS #ASH19. Possibly a great up and coming treatment option for patients!
Image from Caitlin Siebenaller, PharmD, BCOP (@caitlinsiebe)
1
3
15
Understanding the therapeutic landscape for MDS, great #ASH2019 educational session chaired by @MikkaelSekeres 👏 @CleClinicMD #CleClincCancer
Image from Abby Statler (@StatlerA16)
6
.@MikkaelSekeres discusses a presentation on guidelines for older patients with acute myeloid leukemia: #ASH19
1
6
14
Definitely looking 🤰🏼in this photo #36weeks! It is a privilege to discuss our research with the broad community of hematologists attending #ASH19👍 @CleClinicMD @MikkaelSekeres #CleClincCancer – at Florida, USA
Rob Dean, MD (@drrdean) profile pictureRob Dean, MD@drrdean8 Dec 2019
Lots of attention at #ASH19 for @StatlerA16 and her work on how restrictive trial eligibility criteria limit access and applicability of new #leukemia treatments, especially for minority populations. #CleClinicCancer @CleClinicMD
Image from Rob Dean, MD (@drrdean)
1
1
14
Replying to @CleClinicMD @StatlerA16
#ASH19 cle.clinic/2rqr1o6
1
1
Replying to @StatlerA16
@StatlerA16 at it again presenting data on racial disparities in clinical trial enrollment and recommendations to address the issue. A job well done!
Image from Caitlin Siebenaller, PharmD, BCOP (@caitlinsiebe)
1
2
Load more